Researcher from University Hospitals Birmingham Reports on Findings in Crohn's Disease (P548 Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohn's Disease - results from a tertiary IBD centre)

Press/Media

Period12 Feb 2024

Media coverage

1

Media coverage

  • TitleResearcher from University Hospitals Birmingham Reports on Findings in Crohn's Disease (P548 Ustekinumab shows favourable safety profile and drug persistence rates in patients with Crohn's Disease - results from a tertiary IBD centre)
    Media name/outletImmunotherapy Daily
    Country/TerritoryUnited States
    Date12/02/24
    PersonsMarietta Iacucci, Subrata Ghosh
View all 1
View less

Related content